AU592384B2 - Thiazolo(4,5-c)quinolines - Google Patents

Thiazolo(4,5-c)quinolines Download PDF

Info

Publication number
AU592384B2
AU592384B2 AU65089/86A AU6508986A AU592384B2 AU 592384 B2 AU592384 B2 AU 592384B2 AU 65089/86 A AU65089/86 A AU 65089/86A AU 6508986 A AU6508986 A AU 6508986A AU 592384 B2 AU592384 B2 AU 592384B2
Authority
AU
Australia
Prior art keywords
general formula
addition salt
thiazolo
acid addition
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU65089/86A
Other languages
English (en)
Other versions
AU6508986A (en
Inventor
Edit Dr. Berenyi
Katalin Dr. Budai
Zsuzsa Dr. Furst
Berta Dr. Knoll
Jozsef Dr. Knoll
Attila Dr. Mandi
Ildiko Dr. Niklya
Lujza Dr. Petocz
Julia Dr. Timar
Gabriella Dr. Zsila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Gyógyszergyár Zrt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Gyógyszergyár Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Gyógyszergyár Zrt filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU6508986A publication Critical patent/AU6508986A/en
Application granted granted Critical
Publication of AU592384B2 publication Critical patent/AU592384B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65089/86A 1985-11-12 1986-11-12 Thiazolo(4,5-c)quinolines Expired - Fee Related AU592384B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4304/85 1985-11-12
HU854304A HU197019B (en) 1985-11-12 1985-11-12 Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same

Publications (2)

Publication Number Publication Date
AU6508986A AU6508986A (en) 1987-05-14
AU592384B2 true AU592384B2 (en) 1990-01-11

Family

ID=10967593

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65089/86A Expired - Fee Related AU592384B2 (en) 1985-11-12 1986-11-12 Thiazolo(4,5-c)quinolines

Country Status (24)

Country Link
US (1) US4904669A (enExample)
JP (1) JPS62161792A (enExample)
CN (1) CN86107754A (enExample)
AU (1) AU592384B2 (enExample)
BE (1) BE905719A (enExample)
BG (1) BG46156A3 (enExample)
CH (1) CH670829A5 (enExample)
DD (1) DD254202A5 (enExample)
DE (1) DE3638563A1 (enExample)
DK (1) DK539786A (enExample)
ES (1) ES2002543A6 (enExample)
FI (1) FI864611A7 (enExample)
FR (1) FR2603588A1 (enExample)
GB (1) GB2184117B (enExample)
HU (1) HU197019B (enExample)
IL (1) IL80611A0 (enExample)
IT (1) IT1213379B (enExample)
NL (1) NL8602878A (enExample)
NO (1) NO864518L (enExample)
PL (1) PL148186B1 (enExample)
SE (1) SE8604839L (enExample)
SU (1) SU1544190A3 (enExample)
YU (1) YU192186A (enExample)
ZA (1) ZA868583B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
WO2004096144A2 (en) * 2003-04-28 2004-11-11 3M Innovative Properties Company Compositions and methods for induction of opioid receptors
WO2005018556A2 (en) * 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
RU2006105101A (ru) * 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Арилокси и арилалкиленокси замещенные имидазохинолины
WO2005023190A2 (en) * 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US8871782B2 (en) * 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US8598192B2 (en) * 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AR046781A1 (es) * 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) * 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) * 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) * 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
US8026366B2 (en) * 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) * 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US20090270443A1 (en) * 2004-09-02 2009-10-29 Doris Stoermer 1-amino imidazo-containing compounds and methods
EP1819364A4 (en) * 2004-12-08 2010-12-29 3M Innovative Properties Co COMPOSITIONS, IMMUNOMODULATORY COMBINATIONS AND ASSOCIATED METHODS
EP1831226B1 (en) * 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
AU2005326708C1 (en) 2004-12-30 2012-08-30 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) * 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530252A (ja) * 2005-02-09 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシルアミンで置換されたチアゾロ［４，５−ｃ］環化合物ならびに方法
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) * 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US12134616B2 (en) 2018-10-23 2024-11-05 Basf Se Tricyclic pesticidal compounds
EP4136086A1 (en) 2020-04-14 2023-02-22 Basf Se Tricyclic pesticidal compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6508686A (en) * 1985-11-12 1987-05-14 Egis Gyogyszergyar Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024207A (en) * 1978-05-26 1980-01-09 Lepetit Spa New tricyclic ortho-fused heterocyclic compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6508686A (en) * 1985-11-12 1987-05-14 Egis Gyogyszergyar Pharmaceutical compositions

Also Published As

Publication number Publication date
AU6508986A (en) 1987-05-14
PL148186B1 (en) 1989-09-30
FR2603588A1 (fr) 1988-03-11
DD254202A5 (de) 1988-02-17
SE8604839L (sv) 1987-05-13
DK539786D0 (da) 1986-11-12
NO864518L (no) 1987-05-13
IL80611A0 (en) 1987-02-27
ZA868583B (en) 1987-08-26
GB2184117B (en) 1989-10-11
HU197019B (en) 1989-02-28
CH670829A5 (enExample) 1989-07-14
BE905719A (fr) 1987-05-07
FI864611A7 (fi) 1987-05-13
SU1544190A3 (ru) 1990-02-15
GB2184117A (en) 1987-06-17
DK539786A (da) 1987-05-13
NL8602878A (nl) 1987-06-01
US4904669A (en) 1990-02-27
JPS62161792A (ja) 1987-07-17
DE3638563A1 (de) 1987-06-25
GB8627043D0 (en) 1986-12-10
NO864518D0 (no) 1986-11-12
CN86107754A (zh) 1987-08-05
BG46156A3 (en) 1989-10-16
IT1213379B (it) 1989-12-20
ES2002543A6 (es) 1988-08-16
YU192186A (en) 1988-10-31
SE8604839D0 (sv) 1986-11-12
IT8622312A0 (it) 1986-11-12
HUT44260A (en) 1988-02-29
FI864611A0 (fi) 1986-11-12
PL262346A1 (en) 1988-03-03

Similar Documents

Publication Publication Date Title
US4904669A (en) Thiazolo/4,5-c/quinolines as major tranquilizers
DE69919364T2 (de) Pyrroloindole, pyridoindole und azepinoindole als 5-ht2c agonisten
AU754716B2 (en) Amide derivatives and nociceptin antagonists
EP0260817B1 (en) Quinazolinediones and pyridopyrimidinediones
KR940000828B1 (ko) 항혈전성 강심제 이미다조 퀴놀린의 제조방법
EP0088593B1 (en) 1,2,4-triazine and pyrazine derivatives
SK280822B6 (sk) Imidazopyridíny, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
BG60270B2 (bg) Метод за получаване на 5н-2,3-бензодиазепинови производни
JPH0586391B2 (enExample)
MXPA04007242A (es) Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1.
SK283536B6 (sk) Pyridylftalazindióny, spôsob ich prípravy a použitie a farmaceutické prostriedky na ich báze
IE851633L (en) Pyrido-indole compounds
US4778811A (en) Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline
HU220874B1 (en) Imidazopyridine-azolidinones, process for producing them, the use thereof and pharmaceutical compositions containing them
US3953461A (en) Amino derivatives of thiazolo[5,4-b]pyridine-6-carboxylic acids and esters
CA1286668C (en) Imidazo[1,2-a]quinoline derivatives, their preparation and their application in therapy
EP0076559B1 (en) Antiallergic imidosulfamides
AU741162B2 (en) New 2,3-benzodiazepine derivatives
US4424351A (en) Pyrido 3,4-e!-as-triazines
FI102276B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-N,N-dialkyylisulfa moyyli-1H-6,7,8,9-tetrahydro£g|indoli-2,3-dioni-3-oksiimien valmistami seksi
WO1997026247A1 (en) 1-arylphthalazine antagonists of excitatory amino acid receptors
US20200277271A1 (en) Small molecule antagonists of sumo related modification of crmp2 and uses thereof
CS241014B2 (en) Method of 9-aminopyrido-(1,2-a)pyrimidine derivatives production
JPH10505330A (ja) ハロゲンイミダゾピリジン
KR830001347B1 (ko) 4-아닐리노퀴나졸린 유도체의 제조방법